Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HCV / HEPATITIS NEWS - Page 5

Mavyret Approved for Patients with Chronic HCV Genotypes 1-6 Without Cirrhosis
The US Food and Drug Administration approved Mavyret for adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis or with mild cirrhosis.
HBV Reactivation More Severe in HBV/HCV Coinfected Patients Receiving DAA Therapy
A recent study finds that HBV reactivation occurs earlier and is more severe in HBV/HCV coinfected patients treated with DAA therapy compared with patients treated with IFN-based therapy.
New Study Evaluates Risk of HBV Reactivation in Veterans Receiving DAA Therapy
A new study published in the Journal of Hepatology evaluates the risk of HBV reactivation in veterans receiving direct-acting antiviral therapy.
HCV Patients Who Reach SVR With DAA Drugs Show Reduced Risk of Liver Cancer
Study finds that hepatitis C patients who had reached sustained virologic response using direct-acting antiviral drugs show a considerably reduced risk of the most common type of liver cancer.
Using Deep Sequencing Technology to Detect HCV Resistant Variants
A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.
Compound Found in Plums Shown to Inhibit Hepatitis C Virus Entry
A naturally occurring compound in plums has been found to block the entry of the hepatitis C virus into cultured liver cells.
What Is Needed to Eliminate Hepatitis C Virus in the US?
A recent report coming from the O’Neill Institute for National & Global Health Law takes a closer look at the tools needed to achieve hepatitis C elimination in the United States.
FEATURED
Big advances in treatment can